Q2 2025 Holdings
Filed 2025-08-14 | 103 holdings | $4.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Sinovac Biotech LTD(SVA) | SHS | P8696W104 | $334.0M | 2,718,735 | 8.3% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $302.2M | 2,813,200 | 7.5% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $263.2M | 337,600 | 6.6% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $203.4M | 15,518,492 | 5.1% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $159.7M | 7,959,538 | 4.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $158.1M | 291,000 | 3.9% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $144.6M | 8,288,510 | 3.6% |
| Stryker Corporation(SYK) | COM | 863667101 | $142.1M | 359,200 | 3.5% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $133.6M | 1,708,000 | 3.3% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $114.7M | 208,000 | 2.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $111.5M | 341,900 | 2.8% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $104.9M | 336,300 | 2.6% |
| Natera Inc(NTRA) | COM | 632307104 | $100.3M | 593,434 | 2.5% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $93.6M | 210,287 | 2.3% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $81.8M | 465,000 | 2.0% |
| Caris Life Sciences Inc(CAI) | COM | 142152107 | $81.1M | 3,034,858 | 2.0% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $74.9M | 1,415,020 | 1.9% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $65.9M | 3,027,328 | 1.6% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $64.3M | 3,704,959 | 1.6% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $62.5M | 5,693,589 | 1.6% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $55.1M | 438,540 | 1.4% |
| Integer Hldgs Corp(ITGR) | COM | 45826H109 | $53.3M | 433,400 | 1.3% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $51.5M | 1,812,886 | 1.3% |
| CG Oncology Inc(CGON) | COM | 156944100 | $48.8M | 1,877,850 | 1.2% |
| Si-Bone Inc(SIBN) | COM | 825704109 | $48.5M | 2,578,979 | 1.2% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $45.7M | 4,002,887 | 1.1% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $44.7M | 427,900 | 1.1% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $39.6M | 15,219,994 | 1.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $35.6M | 1,077,000 | 0.9% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $33.0M | 1,149,000 | 0.8% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $32.3M | 607,316 | 0.8% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $31.4M | 5,779,071 | 0.8% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $31.3M | 2,779,427 | 0.8% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $29.7M | 947,877 | 0.7% |
| Neuropace Inc(NPCE) | COM | 641288105 | $29.1M | 2,614,184 | 0.7% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $28.7M | 7,165,006 | 0.7% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $28.2M | 7,562,971 | 0.7% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $28.0M | 1,210,300 | 0.7% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $25.7M | 1,482,300 | 0.6% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $24.9M | 1,199,300 | 0.6% |
| Scpharmaceuticals Inc(SCPH) | COM | 810648105 | $23.1M | 6,059,528 | 0.6% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $19.2M | 8,461,500 | 0.5% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $18.9M | 46,500 | 0.5% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $18.6M | 557,900 | 0.5% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $18.1M | 3,308,400 | 0.5% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $15.8M | 5,907,351 | 0.4% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $15.7M | 248,512 | 0.4% |
| Unitedhealth Group Inc(UNH)Call | COM | 91324P102 | $15.6M | 50,000 | 0.4% |
| Forte Biosciences Inc(FBRX) | COM NEW | 34962G208 | $15.5M | 1,196,955 | 0.4% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $14.5M | 1,923,855 | 0.4% |